Ten Largest Investments

Summary by AI ^BETAClose X

JPMorgan European Growth & Income PLC has announced its ten largest investments as a percentage of total assets as of December 31, 2025. The top holding is Asml at 4.0%, followed by Novartis and Roche Holdings, both at 3.5%. Nestle accounts for 2.6%, while Siemens, Unicredit SPA, JPMorgan European Discovery Trust Plc, Banco Santander, and Allianz each represent 2.4%. Safran SA is the tenth largest investment at 2.1%. Collectively, these ten investments comprise 27.6% of the Company's total assets, excluding liquidity stocks.

Disclaimer*

JPMorgan European Grwth & Inc PLC

13 January 2026

JPMORGAN EUROPEAN GROWTH & INCOME PLC (the 'Company')
Legal Entity Identifier: 549300D8SPJFHBDGXS57
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 December 2025
Asml	4.0%
Novartis	3.5%
Roche Holdings	3.5%
Nestle	2.6%
Siemens	2.4%
Unicredit SPA	2.4%
JPMorgan European Discovery Trust Plc	2.4%
Banco Santander	2.4%
Allianz	2.4%
Safran Sa	2.1%
Total	27.6%
Excludes Investments in Liquidity stocks
Name of contact and telephone number for queries:
Paul Ainger 0044 207 742 6524
Name of authorised company official responsible for making this notification:
Paul Winship 0044 207 742 9815 - Company Secretary
Date: 13 January 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END